Parkinsonism
Parkinson’s Disease
• Core features: bradykinesia + resting tremor + rigidity + postural instability.
• Other features: micrographia, hypophonia, shuffling gait, reduced arm swing, facial masking (hypomimia).
• Pathology: loss of dopaminergic neurons in substantia nigra pars compacta; Lewy bodies (α-synuclein).
• Treatment:
o Levodopa (+ dopa decarboxylase inhibitor): most effective for
bradykinesia/rigidity; long-term risk of dyskinesias, motor fluctuations.
o Dopamine agonists (e.g., ropinirole, pramipexole): risk of impulse control disorders.
o MAO-B inhibitors (e.g., selegiline): mild symptomatic benefit.
Atypical Parkinsonism (Parkinson-plus syndromes)
• Multiple System Atrophy (MSA):
o Early autonomic dysfunction (e.g., postural hypotension, erectile dysfunction).
o Cerebellar or pyramidal signs.
• Progressive Supranuclear Palsy (PSP):
o Early postural instability and falls.
o Vertical gaze palsy (esp. downgaze).
• Corticobasal degeneration:
o Asymmetric rigidity, apraxia, "alien limb" phenomenon.
Tremor
Essential Tremor
• Type: action/postural tremor (e.g., holding cup).
• Improves with alcohol, worsens with stress.
• Rx: propranolol (first-line), primidone.
Parkinsonian Tremor
• Type: resting tremor, "pill-rolling."
• Improves with voluntary movement.
Chorea
Huntington’s Disease
• Genetics: autosomal dominant, CAG trinucleotide repeat on chromosome 4.
• Clinical triad: chorea, psychiatric symptoms (depression, irritability), cognitive decline.
• Anticipation: earlier onset in successive generations.
• MRI: caudate nucleus atrophy ("boxcar ventricles").
Sydenham’s Chorea
• Post-streptococcal (Group A beta-haemolytic Strep)
• Associated with rheumatic fever (Jones criteria).
• Self-limiting, supportive treatment ± penicillin prophylaxis.
Dystonia and Myoclonus
• Dystonia: sustained or intermittent muscle contractions → abnormal postures or repetitive movements.
o Causes: idiopathic, medication-induced (dopamine blockers), Wilson’s disease.
• Myoclonus: sudden, brief, shock-like involuntary movements.
o Causes: metabolic (e.g., uraemia), post-hypoxic, epilepsy-related, medications.
Wilson’s Disease
• Inheritance: autosomal recessive (ATP7B gene mutation).
• Pathophysiology: defective copper excretion → copper accumulation in liver, brain, cornea.
• Clinical:
o Hepatic: chronic liver disease, acute hepatitis, fulminant liver failure.
o Neuropsychiatric: dystonia, dysarthria, tremor, behavioural changes.
o Kayser–Fleischer rings (copper deposition in Descemet’s membrane).
• Investigations: ↓ serum ceruloplasmin, ↑ urinary copper excretion, hepatic copper quantification.
• Treatment: chelation (penicillamine), zinc (blocks absorption), liver transplant in fulminant cases.
Extra Revision Pearls
• Essential tremor clue → improves with alcohol
• Early falls clue → PSP (vs Parkinson’s)
• Vertical gaze palsy clue → PSP
• Chorea + behavioural symptoms clue → Huntington’s
• Young liver disease + neuropsychiatric clue → Wilson’s
• Pill-rolling clue → Parkinson’s